Develop Shots Aimed at XBB.1.5 Variant FDA Advises

The FDA said it has advised manufacturers that are updating their COVID-19 vaccines to develop monovalent shots to target the XBB.1.5 subvariant.
Reuters Health Information

source https://www.medscape.com/s/viewarticle/993347?src=rss